American Rhinologic Society 70th Annual Meeting 2024
Include: 64 videos + 1 pdf, size: 2.49 GB
Target Audience: otolaryngologists, rhinologists and sinus surgeons
Information:
The 70th Annual Meeting of the American Rhinologic Society (ARS) will take place on September 27–28, 2024, at the Fontainebleau Miami Beach in Miami, Florida.
Here’s what you can expect:
- Scientific Program: Presentations on cutting-edge research, including topics like machine learning in endoscopy and sinonasal pathology
- Networking: A chance to connect with leaders in rhinology and sinus surgery
- Poster Awards: Recognizing outstanding research contributions
The annual meeting occurs each fall at the time of the annual meeting of the Academy of Otolaryngology – Head & Neck Society.
The ARS is the only professional organization that deals specifically with issues of sinus surgery, both conventional and endoscopic. The ARS promotes excellence in clinical care, investigation and education in the fields of Rhinology and Sinusology. The ARS is dedicated to providing communication and fellowship to its members through ongoing continuing medical education, economic and social programs.
The 70th Annual Meeting of the American Rhinologic Society (ARS) is tailored for professionals involved in the field of rhinology and sinus surgery. The primary target audience includes:
- Otolaryngologists (ENT specialists)
- Rhinologists and sinus surgeons
- Physician assistants and advanced practice providers in ENT
- Medical researchers and academics in rhinologic science
- Residents and fellows specializing in otolaryngology
Topics:
- ARS.70thAnnMtg.PAAG.pdf
- Day 1 General Session 20th Annual David Kennedy Lectureship Drug Development- From Discovery to the Clinic.mp4
- Day 1 General Session AI prediction of IP conversion to SCC using a multi-institutional CT dataset.mp4
- Day 1 General Session Awards Ceremony IFAR Top Reviewers Recognition 1.mp4
- Day 1 General Session Awards Ceremony IFAR Top Reviewers Recognition 2.mp4
- Day 1 General Session Deletion of Nrf2 enhances susceptibility to type 2 inflammation after short term PM2.5 exposure.mp4
- Day 1 General Session Long term outcomes of PRP injections for postviral olfactory loss.mp4
- Day 1 General Session Maurice Cottle – Our Founder Tribute.mp4
- Day 1 General Session Murine model of nose-to-brain delivery of antibodies using minimally invasive nasal depot (MIND).mp4
- Day 1 General Session Panel- CRS- Where are we Headed in Research and Patient Care.mp4
- Day 1 General Session Pathologic dural invasion is associated with regional recurrence in olfactory neuroblastoma.mp4
- Day 1 General Session President’s Address.mp4
- Day 1 General Session Q&A 1.mp4
- Day 1 General Session Q&A 2.mp4
- Day 1 General Session Sinus microbial community changes in chronic rhinosinusitis over one year.mp4
- Day 1 General Session Stem cell therapy to treat Cystic Fibrosis rhinosinusitis.mp4
- Day 1 General Session Steroid-eluting sinus stent versus steroid rinse for maintaining frontal sinus patency.mp4
- Day 1 General Session The effects of allergen immunotherapy (AIT) postsurgery in patients with central compartment atopic disease (CCAD).mp4
- Day 1 General Session Therapeutic efficacy of the Ciprofloxacin Azithromycin sinus stent for p.aeruginosa sinusitis.mp4
- Day 2 General Session 3rd Annual Hwang Family Lectureship.mp4
- Day 2 General Session ARS Business Meeting and Presidential Citations.mp4
- Day 2 General Session Autonomic dysfunction and olfactory loss in long COVID.mp4
- Day 2 General Session Deep learning approach for automated frontal sinus opacification assessment on CT scan.mp4
- Day 2 General Session Immunophenotyping invasive fungal sinusitis survival.mp4
- Day 2 General Session Inflammatory endotypes in CRSwNP- Implications for postop outcomes.mp4
- Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 1.mp4
- Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 2.mp4
- Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 3.mp4
- Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 4.mp4
- Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 5.mp4
- Day 2 General Session Intro.mp4
- Day 2 General Session Olfactory cleft opacification and outcomes improve with expanded intranasal steroid treatment.mp4
- Day 2 General Session Olfactory fossa opacification on CT scan is correlated to nasal IL-5 in chronic rhinosinusitis.mp4
- Day 2 General Session Panel- ARS AAOA – Empty Nose Syndrome- Just a Bunch of Hot Air.mp4
- Day 2 General Session PAR2 activated IL13 Ra1 in eCRS.mp4
- Day 2 General Session Prevalence of Cystic Fibrosis carrier status in chronic rhinosinusitis without nasal polyps.mp4
- Day 2 General Session Q&A 1.mp4
- Day 2 General Session Q&A 2.mp4
- Day 2 General Session Token of appreciation.mp4
- Day 2 Skull Base – Breakout 1 Assessing complications of functional endoscopic sinus surgery in a large national database.mp4
- Day 2 Skull Base – Breakout 1 Assessing the impact of GLP-1R agonists in postsinus surgery management.mp4
- Day 2 Skull Base – Breakout 1 Autologous vs synthetic inlay grafts have comparable skull base reconstructive outcomes.mp4
- Day 2 Skull Base – Breakout 1 Debate- Approaches to the Lateral Frontal Sinus.mp4
- Day 2 Skull Base – Breakout 1 Extended approaches to the maxillary sinus and empty nose syndrome.mp4
- Day 2 Skull Base – Breakout 1 Factors influencing CSF leak timing after ESBS.mp4
- Day 2 Skull Base – Breakout 1 Long-term implications of short-term outcomes after ESS in CRS patients.mp4
- Day 2 Skull Base – Breakout 1 Maxillary antrostomy alone versus complete sinus surgery for odontogenic sinusitis.mp4
- Day 2 Skull Base – Breakout 1 Mutational burden assessment in sinonasal squamous cell carcinoma survival.mp4
- Day 2 Skull Base – Breakout 1 Orbital decompression in the biologic era- Is there still a need for surgery.mp4
- Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 1.mp4
- Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 2.mp4
- Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 3.mp4
- Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 4.mp4
- Day 2 Skull Base – Breakout 1 Panel- “Carve it Out or Melt it Away – Induction Chemotherapy versus Upfront Surgery for Sinonasal Malignancies”.mp4
- Day 2 Skull Base – Breakout 1 Q&A 1.mp4
- Day 2 Skull Base – Breakout 1 Q&A 2.mp4
- Day 2 Skull Base – Breakout 1 Q&A 3.mp4
- Day 2 Skull Base – Breakout 1 Q&A 4.mp4
- Day 2 Skull Base – Breakout 1 Retrobulbar amphotericin B injections versus orbital exenteration in AIFRS outcomes.mp4
- Day 2 Skull Base – Breakout 1 Social vulnerability and quality of life before and after endoscopic skull base surgery.mp4
- Day 2 Skull Base – Breakout 1 The effect of anticoagulant therapy on endoscopic sinus surgery postoperative outcomes.mp4
- Day 2 Skull Base – Breakout 1 Understanding endoscopy and imaging frequency for detection of sinonasal SCC recurrence.mp4
- Day 2 Skull Base – Breakout 1 Unilateral versus bilateral resection of olfactory neuroblastoma.mp4
- Day 2 Skull Base – Breakout 1 Upfront Draf III – Cost-effective in the long run.mp4
- Day 2 Skull Base – Breakout 1 Validation of the sinonasal outcome test-22 in sinonasal malignancy.mp4
